dr Przemysław Danek

dr Przemysław Danek

+48 12 6623389
Stanowisko: Asystent
pokój 3.3
Zakład Farmakokinetyki i Metabolizmu Leków

Dokonania naukowe

  • Publikacje

The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes

Autorzy: Przemysław J. Danek, Władysława A. Daniel

DOI: 10.3390/ijms242316796
Date: 2023-11-27

The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia

Autorzy: Przemysław Jan Danek, Władyslawa Anna Daniel

DOI: 10.3390/cells11213513
Date: 2022-11-01

The Effect of the Selective N-methyl-d-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain

Autorzy: Anna Haduch, Ewa Bromek, Renata Pukło, Joanna Jastrzębska, Przemysław Jan Danek, Władyslawa Anna Daniel

DOI: 10.3390/ijms232213746
Date: 2022-11-01

The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice

Autorzy: Przemysław Jan Danek

DOI: 10.1007/s43440-022-00406-8
Date: 2022-08-26

The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions

Autorzy:

DOI: 10.1016/j.bcp.2022.115006
Date: 2022-05-01

Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats

Autorzy:

DOI: 10.1016/j.neuint.2021.105223
Date: 2022-01-01

Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms

Autorzy: Przemysław Jan Danek, Władyslawa Anna Daniel

DOI: 10.3390/cells10123472
Date: 2021-12-01

Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects

Autorzy:

DOI: 10.1016/j.neuint.2021.105209
Date: 2021-12-01

The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver

Autorzy: Ewa Bromek, Anna Haduch, Marta Rysz, Joanna Jastrzębska, Renata Pukło, Olga Wójcikowska, Przemysław Jan Danek, Władyslawa Anna Daniel

DOI: 10.3390/pharmaceutics13101643
Date: 2021-10-01

The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms

Autorzy: Przemysław Jan Danek, Wojciech Kuban, Władyslawa Anna Daniel

DOI: 10.3390/ijms22168447
Date: 2021-08-01

Zobacz także